[go: up one dir, main page]

WO1993009778A3 - Use of brl 38227 for the treatment and prophylaxis of hyperlipidemia - Google Patents

Use of brl 38227 for the treatment and prophylaxis of hyperlipidemia Download PDF

Info

Publication number
WO1993009778A3
WO1993009778A3 PCT/GB1992/002141 GB9202141W WO9309778A3 WO 1993009778 A3 WO1993009778 A3 WO 1993009778A3 GB 9202141 W GB9202141 W GB 9202141W WO 9309778 A3 WO9309778 A3 WO 9309778A3
Authority
WO
WIPO (PCT)
Prior art keywords
prophylaxis
treatment
hyperlipidemia
brl
mammals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB1992/002141
Other languages
French (fr)
Other versions
WO1993009778A2 (en
Inventor
Thomas Conway Hamilton
Timothy Charles Gadsden Tasker
David Robert Howlett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of WO1993009778A2 publication Critical patent/WO1993009778A2/en
Publication of WO1993009778A3 publication Critical patent/WO1993009778A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A method for the treatment and/or prophylaxis of hyperlipidemia in mammals, which method comprises administering to the mammal in need of such treatment and/or prophylaxis an effective and/or prophylactic amount of BRL 38227.
PCT/GB1992/002141 1991-11-21 1992-11-19 Use of brl 38227 for the treatment and prophylaxis of hyperlipidemia Ceased WO1993009778A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919124754A GB9124754D0 (en) 1991-11-21 1991-11-21 Pharmaceuticals
GB9124754.4 1991-11-21

Publications (2)

Publication Number Publication Date
WO1993009778A2 WO1993009778A2 (en) 1993-05-27
WO1993009778A3 true WO1993009778A3 (en) 1993-07-22

Family

ID=10705002

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1992/002141 Ceased WO1993009778A2 (en) 1991-11-21 1992-11-19 Use of brl 38227 for the treatment and prophylaxis of hyperlipidemia

Country Status (3)

Country Link
AU (1) AU2949592A (en)
GB (1) GB9124754D0 (en)
WO (1) WO1993009778A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0323745A2 (en) * 1988-01-06 1989-07-12 Beecham Group Plc Pharmaceutical preparations
WO1991008741A1 (en) * 1989-12-11 1991-06-27 Beecham Group Plc Use of cromakalim/brl 38227 for the treatment of hyperreactivity of airways

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0323745A2 (en) * 1988-01-06 1989-07-12 Beecham Group Plc Pharmaceutical preparations
WO1991008741A1 (en) * 1989-12-11 1991-06-27 Beecham Group Plc Use of cromakalim/brl 38227 for the treatment of hyperreactivity of airways

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
THE JOURNAL OF LABORATORY AND CLINICAL MEDICINE vol. 114, no. 6, December 1989, pages 646 - 654 FRANK W. ROCKHOLD ET AL 'BENEFICIAL EFFECTS OF PINACIDIL ON BLOOD LIPIDS: COMPARISONS WITH PRAZOSIN AND PLACEBO IN PATIENTS WITH HYPERTENSION' *

Also Published As

Publication number Publication date
WO1993009778A2 (en) 1993-05-27
AU2949592A (en) 1993-06-15
GB9124754D0 (en) 1992-01-15

Similar Documents

Publication Publication Date Title
AU3409293A (en) Method and composition for treating immune disorders, inflammation and chronic infections
BG102668A (en) Application of ppar-alpha and prar-gamma antagonist for the treatment of syndrome x
EP0717592A4 (en) Method and composition for the treatment of apathy-amotivation syndrome
AU7936194A (en) A composition for preventing and treating kinetotia syndrome
PH31600A (en) Methods of inhibiting atrophy of the skin and vagina.
AU678971B2 (en) Compositions and methods for vaccination against coronaviruses
AU5852794A (en) Sterilization devices, sporidical compositions, sterilization methods, and devices for reducing surface tension
EP0591303A4 (en) Methods and compositions for treating malaria and other diseases
AU6946594A (en) Methods for the treatment and prevention of diarrhea
AU8634291A (en) Process and device for the manufacture of high-pressure laminates
GR3021203T3 (en) Process for the preparation of 1,1,1,2-tetrafluoro-2-chloroethan and pentafluorethane.
AU2194792A (en) Fuel oil treatment
GB2271509B (en) Antivenom immunesera
WO1993024117A3 (en) Medicaments for the treatment of anxiety
AU7596994A (en) Methods and compositions for retarding the aging process
WO1993009778A3 (en) Use of brl 38227 for the treatment and prophylaxis of hyperlipidemia
AU7994891A (en) Use of cromakalim/brl 38227 for the treatment of hyperreactivity of airways
EP0725647A4 (en) Using lectins for contraception, prophylaxis and therapy
WO1995003798A3 (en) USE OF CENTRALLY EFFECTIVE α-2 AGONISTS FOR INHIBITING POSTAGGRESSION METABOLISM
AU6953094A (en) Methods and compositions for treating depression and other psychiatric disorders
AU6276494A (en) Method for treating colic and constipation
AU6060694A (en) Method for treating acquired immune deficiency syndrome
AU8497191A (en) Compositions and methods for treating hiv infections
AU2875092A (en) Methods for the treatment of hyperlipidemia using azaspiranes
AU2451792A (en) Methods for treating bycobacterial infections with rifabutin

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP KR US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP KR US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL SE

NENP Non-entry into the national phase

Ref country code: CA

122 Ep: pct application non-entry in european phase